| 160.65 -3.69 (-2.25%) | 06-09 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 200.72 | 1-year : | 234.44 |
| Resists | First : | 171.85 | Second : | 200.72 |
| Pivot price | 160.3  |
|||
| Supports | First : | 142.79 |
Second : | 124.83 |
| MAs | MA(5) : | 162.66 |
MA(20) : | 158.95 |
| MA(100) : | 136.53 |
MA(250) : | 125.24 |
|
| MACD | MACD : | 6.5 |
Signal : | 7.4 |
| %K %D | K(14,3) : | 58.7 |
D(3) : | 63.3 |
| RSI | RSI(14): 57 |
|||
| 52-week | High : | 171.85 | Low : | 98.26 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ NOVT ] has closed below upper band by 48.4%. Bollinger Bands are 4.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 166.55 - 167.47 | 167.47 - 168.22 |
| Low: | 147.45 - 148.67 | 148.67 - 149.65 |
| Close: | 158.75 - 160.67 | 160.67 - 162.22 |
Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.
Tue, 09 Jun 2026
Novanta (NASDAQ: NOVT) to raise $300M in private share placement - Stock Titan
Tue, 09 Jun 2026
Novanta (NOVT) Secures $300M from Private Placement of Common Sh - GuruFocus
Tue, 09 Jun 2026
Novanta (NOVT) to Acquire Riverpoint Medical for $1.2 Billion - GuruFocus
Tue, 09 Jun 2026
Novanta Inc. Announces $300 Million Private Placement - Business Wire
Tue, 09 Jun 2026
Novanta to Acquire Runway Buyer for $1.2 Billion Cash, With $250 Million Milestone - TradingView
Tue, 09 Jun 2026
Novanta (NASDAQ: NOVT) to acquire Riverpoint Medical in $1.45B cash deal - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Hardware, Equipment & Parts
|
|
| Shares Out | 36 (M) |
| Shares Float | 35 (M) |
| Held by Insiders | 0.7 (%) |
| Held by Institutions | 119.3 (%) |
| Shares Short | 4,290 (K) |
| Shares Short P.Month | 4,030 (K) |
| EPS | 1.38 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 36.81 |
| Profit Margin | 5.3 % |
| Operating Margin | 11.6 % |
| Return on Assets (ttm) | 4.5 % |
| Return on Equity (ttm) | 5.1 % |
| Qtrly Rev. Growth | 10.3 % |
| Gross Profit (p.s.) | 12.48 |
| Sales Per Share | 28.08 |
| EBITDA (p.s.) | 5.02 |
| Qtrly Earnings Growth | -13.4 % |
| Operating Cash Flow | 84 (M) |
| Levered Free Cash Flow | 87 (M) |
| PE Ratio | 115.57 |
| PEG Ratio | 0 |
| Price to Book value | 4.36 |
| Price to Sales | 5.72 |
| Price to Cash Flow | 68.12 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|